MEDICAL DEVICE MANUFACTURERS ASSOCIATION lobbying for MEDICAL DEVICE MANUFACTURERS ASSOCIATION

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $300,000.00 expenses · posted Apr 17, 2025

Official filing document

Bills named in this filing 3

HR 3723
Medical Device Electronic Labeling Act
HR 2369
VALID Act of 2023
HR 1691
Ensuring Patient Access to Critical Breakthrough Products Act of 2024

Lobbying activity 5

Copyright/Patent/Trademark

Issues relating to the STRONGER Patents Act and Section 101 reform

Health Issues

Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to the Valid Act of 2023 - H.R. 2369 Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation and reimbursement of artificial intelligence in healthcare Issues related to FDA's third party review program

Medicare/Medicaid

Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 1691 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the New Technology Add on Payment (NTAP) Issues related to Medicare coverage for digital health technologies Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures

Taxation/Internal Revenue Code

Issues related to R&D tax credit

Trade (domestic/foreign)

Issues related to trade and tariffs